The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy

AIDS Patient Care and STDs

Volumn 16, Issue 2, 2002, Pages 75-81

  Welch, Kathleen ^a   Morse, Anne ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CYTOMEGALOVIRUS INFECTION; DEMENTIA; DEMOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KIDNEY DISEASE; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NEGRO; OUTPATIENT CARE; PREVALENCE; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUALITY OF LIFE; RISK FACTOR; SUBSTANCE ABUSE; SURVIVAL RATE; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; FEMALE; HIV WASTING SYNDROME; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERMINALLY ILL; TREATMENT OUTCOME; UNITED STATES;

EID: 0036179670     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910252806126     Document Type: Article

References (37)

1. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
2. The clinical profile of end-stage AIDS
3. The role of initial AIDS-defined illness in survival following AIDS
4. Impact of opportunistic disease on survival in patients with HIV infection
5. Continued decline in morbidity and mortality among patients with advanced HIV infection receiving highly active antiretroviral therapy (HAART)
6. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease
7. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy
8. Decline in specific opportunistic infections (OI) at San Francisco General Hospital
9. Immunological effects of antiretroviral therapy
10. Report on the Sixth Conference on Retroviruses and Opportunistic Infections
11. Decline in Cryptococcus neoformans and Mycobacterium avium complex detection in HIV-infected individuals on highly active anti-retroviral therapy (HAART)
12. Death in HIV-infected patients in the HAART era: An evaluation of mortality in an inner-city hospital
13. Changes in death across Europe
14. Spectrum of disease in persons with human immunodeficiency virus infection in the United States
15. Decline in CMV and other opportunistic diseases with combination antiretroviral therapy
16. Differences in the incidence rates of opportunistic processes before and after the availability of protease inhibitors
17. Trends in incidence of clinical manifestations of HIV infection and antiretroviral prescriptions in French university hospitals
18. Impact of HAART on causes of death of persons with late-stage AIDS
19. AIDS malignancies 1999: A tale of three viruses
20. The impact of primary central nervous system lymphoma in AIDS patients: A population-based autopsy study from Oslo
21. Paradoxical worsening of AIDS-associated progressive multifocal leukoencephalopathy following HAART
22. Fatal progressive multifocal leukoencephalopathy (PML) despite highly active antiretroviral therapy (HAART), interferon-alpha 2b (IFN-a-2b), and peptide T
23. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
24. Epidemiology of human immunodeficiency virus infection and associated neurologic illness
25. Predicting survival in AIDS: Refining the model
26. HIV infection: The spectrum of symptoms and disease in male and female patients attending a London hospice
27. Malnutrition and wasting, immunodepression and chronic inflammation as independent predictors of survival in HIV-infected patients
28. Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992
29. Wasting in HIV infection and AIDS
30. Characteristics of HIV-infected men with low serum testosterone levels
31. Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy
32. Long term survival in HIV-1 infected patients with neurological disorders treated with HAART: Analysis of clinical, immunological and virological predictors
33. AIDS-related primary CNS lymphoma: A brief review
34. Opportunistic infections: Still a problem, even in the era of HAART